Literature DB >> 1849044

Decreased expression of tissue inhibitor of metalloproteinases in metastatic tumor cells leading to increased levels of collagenase activity.

A Ponton1, B Coulombe, D Skup.   

Abstract

We have examined the expression of murine tissue inhibitor of metalloproteinases (TIMP) in nonmetastatic and metastatic cell lines derived from SP1 murine mammary adenocarcinoma cells. We observed decreased levels of TIMP mRNA and activity in metastatic cells as compared to their nonmetastatic equivalents in the absence of fetal bovine serum. Lower levels of TIMP mRNA correlated to decreased levels of transcription of the TIMP gene. Net collagenase activity was higher in metastatic cells, but metastatic and nonmetastatic cells secreted similar levels of total collagenase (mainly type IV). This suggests that decreased TIMP gene expression results in increased net collagenase activity in malignant cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1849044

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  22 in total

1.  The architecture of cancer.

Authors:  J Waxman; H Wasan
Journal:  BMJ       Date:  1992-11-28

Review 2.  The role of tissue inhibitor of metalloproteinase-1 in specific aspects of cancer progression and reproduction.

Authors:  R Khokha; P Waterhouse
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

Review 3.  The matrix metalloproteinases and their inhibitors in pancreatic cancer. From molecular science to a clinical application.

Authors:  S R Bramhall
Journal:  Int J Pancreatol       Date:  1997-02

4.  In situ hybridization studies of metalloproteinases 2 and 9 and TIMP-1 and TIMP-2 expression in human prostate cancer.

Authors:  M Wood; K Fudge; J L Mohler; A R Frost; F Garcia; M Wang; M E Stearns
Journal:  Clin Exp Metastasis       Date:  1997-05       Impact factor: 5.150

5.  Ovarian cancer cell invasion is inhibited by paclitaxel.

Authors:  A Westerlund; E Hujanen; M Höyhtyä; U Puistola; T Turpeenniemi-Hujanen
Journal:  Clin Exp Metastasis       Date:  1997-05       Impact factor: 5.150

6.  Expression of cysteine protease inhibitors in human gliomas and meningiomas.

Authors:  M Sivaparvathi; I McCutcheon; R Sawaya; G L Nicolson; J S Rao
Journal:  Clin Exp Metastasis       Date:  1996-09       Impact factor: 5.150

Review 7.  Role of the extracellular matrix in the degradation of connective tissue.

Authors:  C Mauch; T Krieg; E A Bauer
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

8.  Differential expression of SKALP/Elafin in human epidermal tumors.

Authors:  H A Alkemade; H O Molhuizen; I M van Vlijmen-Willems; U J van Haelst; J Schalkwijk
Journal:  Am J Pathol       Date:  1993-12       Impact factor: 4.307

9.  Development of an in vitro extracellular matrix assay for studies of brain tumor cell invasion.

Authors:  A P Amar; S J DeArmond; D R Spencer; P F Coopersmith; D M Ramos; M L Rosenblum
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

Review 10.  Adhesion molecules and their role in cancer metastasis.

Authors:  R M Lafrenie; M R Buchanan; F W Orr
Journal:  Cell Biophys       Date:  1993 Aug-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.